Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Lion Point Capital, LP | 81.2K | -- | 0.09% | -- | 2026-06-30 |
| Morgan Stanley | 43.5K | -- | 0.05% | -- | 2026-06-30 |
| XTX Topco Ltd | 15.1K | -- | 0.02% | -- | 2026-06-30 |
| Citadel Advisors LLC | 12.4K | -- | 0.01% | -7.6K | 2026-06-30 |
| Jane Street Group, LLC | 10.3K | -- | 0.01% | -33.1K | 2026-06-30 |
| Rhumbline Advisers | 4.7K | -- | 0.01% | -15 | 2026-06-30 |
| UBS Group AG | 1.4K | -- | 0.00% | +416 | 2026-06-30 |
